【摘要】 目的：评价并比较一切口和二切口超声乳化白内障吸除术联合小梁切除术治疗白内障合并青光眼的疗效和耐受性。方法：按照Cochrane协作网方法全面检索符合纳入标准的比较一切口和二切口超声乳化白内障吸除术联合小梁切除术的临床对照研究，将其进行荟萃分析。临床疗效的评估包括：眼压下降百分比采用标准化均差(SMD)，术后最佳矫正视力≥0.5的患者百分比采用比值比(OR)，手术成功率采用相对危险度(RR)。临床耐受性的评估采用RR。所有结果均以95%可信区间表示。数据分析采用Stata 10.1。结果：降低眼压的临床疗效二切口术式明显优于一切口术式，差异具有统计学意义(SMD，0.19;95% CI，0.33到 0.04;P=0.01);术后最佳矫正视力≥ 0.5的患者百分比二切口术式大于一切口术式，但差异不具有统计学意义(OR，0.65;95% CI，0.30到1.39;P=0.26);术后不加用抗青光眼药物达到靶眼压的患者百分比二切口术式大于一切口术式，但差异不具有统计学意义(RR, 0.94; 95% CI, 0.84到1.04; P=0.22);两种术式在术后并发症方面差别无统计学意义。结论：二切口超声乳化白内障吸除术联合小梁切除术临床疗效优于一切口术式。两种术式的术后并发症没有明显差异。
【关键词】 超声乳化白内障吸除术联合小梁切除术;一切口;二切口;荟萃分析
INTRODUCTION
With the increasing elderly population and concurrent longevity in life expectancy, there is an increase in the incidence of coexisting visually significant cataract and glaucoma. One of the challenges in the management of surgical procedure is difficulty in solving these two problems simultaneously. Phacoemulsification alone may be beneficial in some cases, which results in better intraocular pressure (IOP) than planned extracapsular cataract extraction procedures, and performing the glaucoma filtering surgery first and the cataract surgery later may best serve others[1]. However, there is a widespread shift towards the use of combined phacotrabeculectomy as the surgical treatment of choice for coexisting cataract and glaucoma in recent years[24].
Phacotrabeculectomy can be performed either using onesite or twosite incisions[5]. The earliest clinical studies of phacotrabeculectomy which is known as a onesite procedure reported surgical results using the same the scleral tunnel incision for both the phacoemulsification and trabeculectomy parts of the surgery. The introduction of the temporal incision for phacoemulsification has allowed surgeons to perform twosite procedure, with a prelimbal filtering incision for the trabeculectomy and a separate clear cornea incision for phacoemulsification[5]. Comparing of the two surgical procedures, previous studies generally had small sample sizes and showed conflicting results, which greatly hindered researchers drawing correct conclusions.
A metaanalysis of controlled clinical trials (prospective or retrospective) was conducted to assess the efficacy and tolerability of two surgical procedures for the management of coexisting cataract and glaucoma: onesite and twosite phacotrabeculectomy. This metaanalysis was designed to help resolve ambiguity regarding optimal management of coexisting cataract and glaucoma by pooling the outcome of available studies. Our analysis controlled for differences in study sizes and patient characteristics. However, we recognize the limitations introduced by differences in study protocols, publication bias, and the quality of studies.
MATERIALS AND METHODS
Search Strategy A computerized literature search was conducted in the PubMed, EMBASE, Scientific Citation Index and Cochrane Controlled Trials Register for relevant articles published up to May 2009. And extensive search for meeting archives, including the annual meeting abstracts of American Association of Ophthalmology (AAO) and Association for Research in Vision and Ophthalmology (ARVO) was also carried out up to May 2009. These databases were searched systematically using the following key words: phacotrabeculectomy, phacoemulsification and trabeculectomy, combined phacoemulsification and trabeculectomy, combined phaco/trabeculectomy, combined cataract and glaucoma surgery, combined cataractglaucoma surgery,onesite phacotrabeculectomy, twosite phacotrabeculectomy. The search strategy used both keywords and Medical Subject Headings (MeSH) terms. There were no limits placed on the language of publication. All potentially relevant nonEnglish publications were to be translated into English for further assessment. Literature reference proceedings were searched manually at the same time. The title and abstract of all potentially relevant articles were screened to determine their relevance. Then, full articles were scrutinized if the title and abstract were ambiguous. References identified from bibliographies of pertinent articles or books also were retrieved. References of included publications were reviewed until no further relevant studies were found.
Inclusion and exclusion criteria Only controlled clinical trials directly comparing between onesite and twosite phacotrabeculectomy in patients with coexisting cataract and glaucoma were included, antimetabolites could be used intraoperatively. Studies needed to have measured efficacy, tolerability or both in humans. Outcome variables included at least one of the following primary outcome variables: intraocular pressure reduction (IOPR), the percentage having a bestcorrected visual acuity (BCVA) of 0.5 or better after surgery, complete success rates and adverse events, or relevant data. Abstracts from conferences and full texts without raw data available for retrieval, duplicate publications, letter and review were excluded.
Studies selection The assessment of the titles and abstracts for eligibility was conducted by two independent reviewers (Liu HN and Nie QZ). Articles of potential interest were retrieved and their inclusion was reassessed. Disagreement at each step was resolved with discussion between the two reviewers. We obtained the full article of any study that seemed to fit the inclusion criteria.
Data extraction Two reviewers (Liu HN and Nie QZ) performed the data extraction that were included independently. Any differences were resolved by discussion to reach consensus among the investigators. A customized form was used to record authors of study, publication year, location, design, followup time, sample size, patient characteristics, interventions, baseline and endpoint values, and adverse events.
Outcome measures For efficacy, we used the percentage intraocular pressure reduction (IOPR%) in preoperative to postoperative IOP. Secondary efficacy measure was the percentage having a postoperative BCVA of 0.5 or better and complete success rate, which was defined as the proportion of patients achieved the target IOP without antiglaucoma medication at the end point. We assessed tolerability to phacotrabeculectomy by considering the proportions of patients with adverse events, including hyphema, choroidal detachment, bleb leak, hypotony, posterior capsule opacification and shallow anterior chamber.
Statistical analysis Extracted data were pooled for summary estimates using Stata 10.1 for Windows (StataCorp LP, College Station, TX, USA). Continuous outcomes were expressed as standardised mean difference (SMD), with values <0 favouring twosite phacotrabeculectomy,and dichotomous outcomes as odds ratio (OR) or relative risk (RR). Both outcomes were reported with 95% confidence interval (CI). P<0.05 was considered statistically significant on the test for overall effect. Intertrial statistical heterogeneity was explored using the DerSimonian and Laird Q test, with calculated I2 indicating the percentage of the total variability in effect estimates among trials that is due to heterogeneity rather than chance. If heterogeneity tests were nonsignificant, fixed effects models were used, as they provide narrower 95% CIs than the equivalent random effects models, which are more appropriate where significant heterogeneity is detected. The Begg and Egger tests were used to assess for publication bias.
For studies that only reported absolute values for IOP at baseline and end point, the IOPR, standard deviation (SD) of the IOPR (SDIOPR), IOPR% and SD of the IOPR% (SDIOPR%) were calculated as follows: IOPR = IOPbaselineIOPend point, SDIOPR= (SDbaseline2+ SDend point2 SDbaseline ×SDend point)1/2, IOPR% = IOPR/ IOPbaseline, SDIOPR%= SDIOPR/ IOPbaseline. The difference of IOPR and its SD between groups was then calculated for each individual study.
RESULTS
Description of studies Seventeen potentially relevant controlled clinical trials associated with onesite and twosite phacotrabeculectomy in the treatment of coexisting cataract and glaucoma were identified through the literature search. Among these, four articles without exact raw data available for retrieval according with the exclusion criteria were excluded; two abstract reports were found in the annual meeting abstracts of ARVO; eleven controlled clinical trials that fulfilled the eligibility criteria were included in the present metaanalysis[616]. These were published in 8 different journals in English, Chinese and Spanish and no unpublished data were identified(Table 1).
Efficacy Effect sizes (SMD in patients with onesite and twosite phacotrabeculectomy on IOPR%) from the fixed effects model for all are prospective and retrospective studies, respectively (Figure 1). Twosite phacotrabeculectomy was associated with numerically lower IOPR% relative to onesite in all studies, except for those by Mandic et al[9] and Buys
et al[15]. Both surgical procedures significantly decreased IOP. The pooled summary estimate for all 11 studies favoured
Table 1Characteristics of included studies
AuthorsYearCountryDesignFollowup
(χ,mo)Participants
(n)Age
(χ,yr)M/FEyes(n)1site2site
Wyse et al[6]1998USAPro16.53375.07/262013
el Sayyad et al[7]1999Saudi ArabiaPro127665.5NA3739
Borggrefe et al[8]1999GermanyPro195074.316/342525
Mandic et al[9]2000CroatiaPro125571.617/222731
Zou et al[10]2001ChinaRetro18.94561.229/162918
IsasiSaseta et al[11]2002SpainRetro63576.416/191916
Dong et al[12]2004ChinaRetro123560.916/191525
Shingletonet al[13]2006USARetro12130NANA7164
Cotran et al[14]2007USAPro367675.426/504343
Buys et al[15]2008CanadaPro247970.929/503940
Nassiri et al[16]2008IranRetro1811368.855/586152
NA: not available.
Figure 1SMD in patients with onesite and twosite phacotrabeculectomy on IOPR%from the fixed effects model.
twosite procedure, and showed twosite phacotrabeculectomy was more effective than onesite in lowering IOP (SMD, 0.19; 95% CI, 0.33 to 0.04; P=0.01). No significant heterogeneity was presented between studies in the onesite versus twosite groups (χ2= 8.86, P=0.55,I2=0.0%). Then, we divided the studies into two subgroups according to study design (prospective and retrospective). Both prospective and retrospective subgroups showed that twosite approach was associated with numerically lower IOPR relative to onesite procedure, but no significant difference was found. There was no significant heterogeneity in these analysis. Publication bias was also tested using the Begg test (P=0.28) and the Egger test (P=0.34), and both produced nonstatistically significant results, providing no evidence of publication bias.
Three studies involving 166 eyes compared onesite with twosite procedure in visual acuity after phacotrabeculectomy (69% onesite and 78% twosite)[7,8,12]. No statistical heterogeneity was observed between studies (χ2= 0.10, P= 0.95,I2=0.0%). The combined result showed there was nonsignificant statistically difference in the percentage having a BCVA of 0.5 or better (OR, 0.65; 95% CI, 0.30 to 1.39, P=0.26).Seven studies, involving 426 eyes, reported the proportions of twosite patients than onesite patients achieved the target IOP without antiglaucoma medication at the end point (73% onesite and 79% twosite)[610,14,15]. No statistical heterogeneity was showed between studies (χ2=8.71, P= 0.19,I2= 31.1%), and the difference between groups was not statistically significant (RR, 0.94; 95% CI, 0.84 to 1.04; P= 0.22).
Tolerability Adverse events in controlled clinical trials comparing between onesite and twosite phacotrabeculectomy are showed in Table 2. Hyphema was one of the most commonly reported postoperative adverse events. However, no
[1] [2] 下一页 |
